Connect with us

Technology

POMDOCTOR LIMITED Advances Strategic Evolution from Traffic Monetization to Value-Based Healthcare Payment

Published

on

Building a Four-Tier Revenue Structure Across B2C Services, AI-Enabled Chronic Disease Management, B2B Healthcare Services, and Pharmaceutical RWS/RWD

GUANGZHOU, China, Nov. 4, 2026 /PRNewswire/ — POMDOCTOR LIMITED (“Pomdoctor” or the “Company”) (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions, today provided an overview of its strategic evolution and business model transformation amid the rapid development of China’s digital healthcare industry. Since its establishment in 2010, Pomdoctor has progressively evolved from the industry’s early “traffic monetization” model toward a more diversified and value-oriented healthcare ecosystem, culminating in its current four-tier revenue structure spanning B2C healthcare services, AI-enabled chronic disease management, B2B enterprise and hospital services, and pharmaceutical real-world study (“RWS”) and real-world data (“RWD”) services.

From Traffic Monetization to Diversified Healthcare Services

Pomdoctor was established in 2010, when China’s digital healthcare industry was entering an early stage of transformation. At the time, the prevailing business model centered on “traffic monetization,” with online consultations and pharmaceutical e-commerce generating revenue primarily through user acquisition, engagement, and pharmaceutical sales. As major participants from the e-commerce and pharmaceutical sectors entered the market, competition intensified, placing increasing pressure on the sustainability and differentiation of this model.

Recognizing the structural limitations of relying primarily on user traffic and pharmaceutical transactions, including patients’ limited willingness to pay directly for healthcare services, constrained health insurance coverage, and limitations in advertising-based monetization, Pomdoctor began developing a more diversified business model. The Company expanded beyond a purely service-oriented model and introduced subscription-based offerings supported by more refined operations and specialized healthcare services, establishing an early foundation for recurring and diversified revenue generation.

Expansion into B2B and Hospital Services

As the digital healthcare industry continued to evolve, Pomdoctor further expanded into B2B services, leveraging its healthcare expertise and digital capabilities to provide digital marketing solutions for pharmaceutical companies. Over time, this business evolved from pharmaceutical-focused digital services toward deeper engagement with healthcare institutions, including public hospitals.

This transition enabled Pomdoctor to broaden its role within the healthcare ecosystem, from serving individual users to connecting patients, healthcare providers, pharmaceutical companies, and other enterprise stakeholders. The Company believes this accumulated experience and institutional connectivity have provided an important foundation for its subsequent expansion into higher-value healthcare services.

Leveraging AI and Data to Unlock New Value

With the emergence of artificial intelligence (“AI”) as a transformative force across the healthcare industry, Pomdoctor has continued to build on its existing capabilities by developing and piloting AI-enabled healthcare programs with the objective of converting clinical applications into scalable, revenue-generating services. At the same time, the Company’s accumulated healthcare data assets have created opportunities for higher-value applications in chronic disease management, pharmaceutical research, and other data-driven healthcare services.

By integrating AI technologies, wearable devices, and its existing digital healthcare infrastructure, Pomdoctor is developing a more integrated ecosystem designed to connect patient services, chronic disease management, healthcare institutions, pharmaceutical companies, and data-driven applications. The Company believes this integrated approach can progressively transform data assets from primarily operational resources into sources of incremental commercial value. The Company’s AI-enabled chronic disease subscriptions and pharmaceutical RWS/RWD services are at an early stage of commercialization.

Building a Four-Tier Revenue Structure

Pomdoctor’s current business model is structured around four interconnected revenue tiers:

B2C Basic Healthcare Services — providing an entry point for patients and users through core digital healthcare services;AI-Enabled Chronic Disease Membership Subscriptions — extending user relationships through personalized, technology-enabled chronic disease management and recurring subscription services;B2B Enterprise and Hospital Services — leveraging the Company’s healthcare capabilities and institutional relationships to provide digital solutions and services to enterprises and healthcare institutions; andPharmaceutical RWS/RWD Services — leveraging accumulated healthcare data, clinical experience, and AI capabilities to support pharmaceutical companies in real-world studies (“RWS”) and real-world data (“RWD”) applications.

Together, these four tiers are designed to create a progressive value chain rather than operate as independent revenue streams. B2C services provide the foundation for patient engagement and healthcare data accumulation; AI-enabled chronic disease subscriptions deepen patient relationships and enhance recurring revenue; B2B enterprise and hospital services broaden the Company’s institutional reach and commercial applications; and the resulting data and healthcare infrastructure create a foundation for higher-value pharmaceutical RWS/RWD services.

Pomdoctor believes this interconnected model is designed for longer-term growth opportunities, while creating a potential flywheel effect in which expanding users, healthcare services, institutional relationships, AI applications, and data assets reinforce one another and support the Company’s ongoing transition toward more value-based healthcare monetization.

Management Commentary

Mr. Zhenyang Shi, Chairman and Chief Executive Officer of Pomdoctor, commented: “Since our inception, we have continuously sought distinctive and sustainable ways to create value as the healthcare industry evolves through successive waves of business model and technological change. From our early focus on digital healthcare services, to the development of subscription-based offerings and B2B healthcare services, and now to AI-enabled chronic disease management and data-driven pharmaceutical services, we have consistently endeavored to invest ahead of emerging industry trends while building upon our existing capabilities.

“Today, Pomdoctor is focused on further strengthening our four-tier revenue structure and integrating these businesses into a more comprehensive healthcare ecosystem. We believe the combination of healthcare services, AI, institutional capabilities, and data assets provides a scalable foundation for our next stage of growth. With our experience and capabilities in China, we are also exploring opportunities to replicate and adapt this model in key international markets. We remain committed to continuously improving our business model, expanding our ecosystem, and translating our operational capabilities and innovation into sustainable long-term value for our shareholders.”

About POMDOCTOR LIMITED

POMDOCTOR LIMITED (NASDAQ: POM) is a digital healthcare company focused on advancing AI-enabled healthcare solutions and expanding predictive healthcare capabilities. The Company leverages physician resources, wearable technologies, artificial intelligence, healthcare payment networks and real-world healthcare data to support more personalized, continuous and data-driven healthcare services. Building upon its established healthcare platform and physician network, POM is pursuing the development of a predictive healthcare data and services infrastructure designed to improve healthcare outcomes and create long-term value for patients, healthcare providers and other ecosystem participants. For more information, please visit the Company’s website: http://ir.7shiliu.com.

Forward-Looking Statements

This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements are made under the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding: the Company’s strategic evolution from a traffic monetization model toward value-based healthcare payment and monetization; the Company’s plans to further strengthen its four-tier revenue structure spanning B2C basic healthcare services, AI-enabled chronic disease membership subscriptions, B2B enterprise and hospital services, and pharmaceutical RWS/RWD services, and to integrate these businesses into a more comprehensive healthcare ecosystem; the Company’s development and piloting of AI-enabled healthcare programs and its ability to convert clinical applications into scalable, revenue-generating services; the Company’s plans to integrate AI technologies, wearable devices and its existing digital healthcare infrastructure, and its belief that such integration can progressively transform data assets into sources of incremental commercial value; the Company’s expectations regarding growth in recurring subscription revenue, the expansion of its institutional reach and relationships with healthcare institutions, including public hospitals, and pharmaceutical companies, and the development of higher-value pharmaceutical RWS/RWD services; the Company’s belief that its interconnected business model is designed to balance near-term revenue generation and cash flow with longer-term growth opportunities and to create a potential flywheel effect; the Company’s exploration of opportunities to replicate and adapt its business model in key international markets; and the anticipated benefits of the Company’s strategy for patients, healthcare providers, pharmaceutical companies, shareholders and other ecosystem participants, including sustainable long-term value creation. Investors can identify many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects,” “anticipates,” “aims,” “estimates,” “projects,” “intends,” “plans,” “pursues,” “positions,” “will,” “would,” “should,” “could,” “may” or other similar expressions. These forward-looking statements are based on the Company’s current expectations, assumptions and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs, and involve known and unknown risks and uncertainties, many of which are beyond the Company’s control. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and investors are cautioned not to place undue reliance on these forward-looking statements. All forward-looking statements speak only as of the date of this announcement, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, except as may be required by law.

Actual results may differ materially from those expressed or implied in these forward-looking statements due to a number of factors and uncertainties. Investors are urged to review the section entitled “Item 3. Key Information—D. Risk Factors” in the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2025 filed with the U.S. Securities and Exchange Commission (the “SEC”) on May 14, 2026, and the Company’s other filings with the SEC, which are available on the SEC’s website at www.sec.gov.

For more information, please contact:

POMDOCTOR LIMITED
Investor Relations Department
Email: ir@7lk.com

Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com

View original content:https://www.prnewswire.com/news-releases/pomdoctor-limited-advances-strategic-evolution-from-traffic-monetization-to-value-based-healthcare-payment-302927633.html

SOURCE POMDOCTOR LIMITED

Continue Reading

Technology

Cyware Ranked in Fastest-Growing Company in North America on the 2026 Deloitte Technology Fast 500™

Published

on

By

Attributes Revenue Growth to Demand for AI-Powered Threat Intelligence Prioritization, Context-Driven Action, and Collective Defense

NEW YORK, Nov. 18, 2026 /PRNewswire/ — Cyware, the leader in AI-powered threat intelligence and collective defense, today announced that it ranked once again on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing tech companies in North America, now in its 32nd year. Cyware’s recognition on the Deloitte Technology Fast 500 in 2022, 2024, 2025, and now 2026—marking three consecutive years and four appearances overall—is a testament to the company’s sustained momentum and leadership in cybersecurity innovation.

“Security teams need more than threat data. They need to understand which threats matter to their organization, why they matter, and what to do next,” said Anuj Goel, CEO of Cyware. “We combine agentic AI, threat intelligence, and context from customers’ assets and security tools to create clear priorities and automate action. Through trusted sharing, what one organization learns can help others strengthen their defenses. Our growth reflects the demand for both: intelligence that drives action within each enterprise and collective defense that extends across organizations.”

“The 2026 rankings demonstrate that established momentum and breakthrough growth can drive sustained market leadership,” said Justin Yahr, Audit & Assurance partner and National Emerging Growth Company leader, Deloitte & Touche LLP. “Nearly 70% of this year’s award winners returned as repeat honorees, reflecting the power of disciplined and sustained execution. More than 30% made the list for the first time, illustrating how quickly new players are shaping their respective sectors. Furthermore, private companies represented almost 80% of the list, a clear indication that the agility and strategic focus of private enterprises remain essential to scaling in competitive markets.”

Overall, the 2026 Technology Fast 500 companies achieved revenue growth ranging from 97% to 66,330% over the three-year time frame, with an average growth rate of 1,134%.

About the 2026 Deloitte Technology Fast 500
Now in its 32nd year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2022 to 2025.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or proprietary technology that significantly contributes to the company’s operating revenues. Companies must have base-year (fiscal year 2022) operating revenues of at least US$50,000, and current-year (fiscal year 2025) operating revenues of at least US$5 million, with a growth rate of 50% or greater. Additionally, companies must be in business for a minimum of four years and be headquartered within North America (United States and Canada).

About Cyware
Cyware is leading the industry in AI-powered threat intelligence and collective defense, providing the context layer that helps security teams leverage agentic AI to transform threat intelligence from fragmented data points to actionable, real-time decisions. We unify threat intelligence management, intel sharing and collaboration, as well as orchestration and automation, enabling organizations to outmaneuver adversaries faster and more effectively. From global enterprises and government agencies to the smallest members of ISACs, ISAOs, and state sharing networks, Cyware empowers defenders to turn intelligence into impact. To learn more about Cyware, visit www.cyware.com.

About Deloitte
*Please see www.deloitte.com/us/about for a detailed description of their legal structure.

Public Relations Contact:
Danielle Ostrovsky
Hi-Touch PR for Cyware
Ostrovsky@Hi-TouchPR.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cyware-ranked-in-fastest-growing-company-in-north-america-on-the-2026-deloitte-technology-fast-500-302944050.html

SOURCE Cyware

Continue Reading

Technology

BirchStreet Launches Smart Inventory to Give Hospitality Operators Real-Time Stock Control

Published

on

By

AI-powered solution brings item management, mobile counts and replenishment insights into one workspace

LAS VEGAS, Nov. 18, 2026 /PRNewswire/ — BirchStreet, the global hospitality operations platform, today announced the launch of Smart Inventory, a solution that helps hospitality organizations track stock accurately, reduce waste and make better purchasing decisions. Smart Inventory combines an interactive inventory list, count management, replenishment insights and AI-powered item intelligence in a single workspace along with mobile capability.

Smart Inventory is now generally available to BirchStreet customers.

Key capabilities include:

AI-Powered Mobile Counting: Count from the floor with an app that automatically identifies and counts items, including liquor fill levels.Easy Item Creation: Add a new item with just a description, category and base unit of measure.Audit Trails and Exception Alerts: Built-in audit trails and instant exception alerts reduce manual steps in each month-end count and can improve count cycle time up to 50%.Reporting: Real-time visibility into stock and live variance review help teams complete month-end close faster.

More than 10,000 properties worldwide have used BirchStreet’s inventory management solution. The new Smart Inventory product extends that foundation with AI-powered tools designed to reduce manual work for operations teams.

“Before implementing BirchStreet Smart Inventory solution, inventory counting required clipboards, spreadsheets, and hours of manual work,” said Adam Butts, SVP Procurement Operations, Crescent Hotels & Resorts. “Now, our teams walk the floor using a phone while the AI counts everything, including the fill levels of open bottles. Smart Inventory provides us with a real-time, accurate view of our inventory. As a result, we have greater visibility, faster counts, and more reliable data, while reducing the costs associated with potential write-offs. Our employees can focus on managing operations rather than tracking numbers.”

“Our new AI-powered Smart Inventory is a clear example of BirchStreet’s continuous innovation in the product suite, and it will help deliver even more value to our customers,” said Swetha Beepyata, SVP Product Management, BirchStreet.

For more information, visit birchstreetai.com.

About BirchStreet
Founded in 2002, BirchStreet is the leading global hospitality operations platform. BirchStreet’s AI-enabled platform provides global hospitality brands and owners with a full suite of procure-to-pay applications, including eProcurement, accounts payable automation, invoice management, inventory management, recipe management, supplier payments, and analytics. BirchStreet’s customers leverage the company’s solutions to access a broad network of suppliers and manage tens of billions of spend annually across a wide variety of categories, including food and beverage, operating supplies, maintenance services, and capital projects. For more information, visit birchstreetai.com.

Media Contact

Irina Jakovleva
Chief Marketing Officer, BirchStreet
ijakovleva@birchstreet.net

View original content to download multimedia:https://www.prnewswire.com/news-releases/birchstreet-launches-smart-inventory-to-give-hospitality-operators-real-time-stock-control-302944090.html

SOURCE BirchStreet Systems

Continue Reading

Technology

European business leaders back growth despite economic uncertainty as Azets launches international Future of Finance report

Published

on

By

New research across six European countries reveals growing confidence in technology-led growth, alongside concerns over cybersecurity, skills and the changing role of finance

LONDON, Nov. 18, 2026 /PRNewswire/ — Azets, the international accountancy and business advisory group, has launched its inaugural Future of Finance report, revealing renewed ambitions for growth among European business leaders despite continued economic uncertainty, rising costs and mounting pressure to adapt.

Based on research among 241 senior business and finance leaders across the UK, Ireland, Denmark, Finland, Norway and Sweden, The Future of Finance: Azets Predicts identifies five major trends set to shape businesses and their finance functions in 2027 and beyond.

Highlights:

57% of business leaders intend to pursue growth over the next 12 months, despite challenging conditions.76% believe smaller businesses will outperform larger competitors through faster adoption of technology.90% expect to have access to real-time financial information within three years, transforming how businesses make decisions.85% believe finance teams will spend more time driving business decisions, rather than simply reporting financial performance.34% identify security, data protection and cyber risk as the biggest barriers to greater use of AI and automation, ahead of cost at 22%.79% predict businesses will stop hiring junior finance professionals as software takes over routine tasks, and will come to regret it.

The findings reveal a striking combination of optimism and caution. While 73% of respondents believe business pressures will worsen before they improve, 86% describe their businesses as thriving or confident. This resilience comes despite 41% reporting that they have had to work harder to achieve growth over the past year.

Technology is central to these ambitions. Half of respondents identify investment in technology infrastructure, automation or more effective use of AI as their primary route to growth. However, the research also highlights the challenges businesses must overcome to realise these opportunities, with cybersecurity, data protection and skills among the most pressing concerns.

Chris Horne, Group CEO at Azets, said:

“Businesses are entering 2027 with considerable challenges ahead, but our research shows that confidence and ambition remain strong. Leaders recognise that waiting for economic conditions to improve is unlikely to be a winning strategy. They are looking for opportunities to grow, become more productive and build greater resilience.”

“Technology will undoubtedly play a defining role, but the greatest opportunities will come from how businesses use it. AI and automation can transform productivity, improve decision-making and free people to focus on higher-value work. Realising that potential requires investment in skills, strong governance and a clear understanding of where technology can make a real difference.”

“One of the most significant findings is how quickly expectations of finance are changing. Businesses increasingly want real-time insight, forward-looking advice and greater support with strategic decisions. That presents a tremendous opportunity for finance professionals and their advisers to play a more influential role in shaping business performance.”

The report identifies five interconnected trends that Azets predicts will shape the business landscape in 2027, highlighting how organisations are responding to economic pressures, technological change and evolving expectations of their finance functions.

Pushing ahead despite adversity

Despite challenging conditions, businesses remain ambitious, with leaders increasingly focused on improving productivity, strengthening margins and making better use of existing resources. The report predicts that businesses prepared to pursue opportunities rather than wait for more favourable conditions will be better positioned for growth.

The agility advantage

Smaller businesses have an opportunity to gain ground on larger competitors by adopting new technologies more quickly. However, the report cautions that size alone is no guarantee of success, with the greatest advantages going to organisations able to combine speed, adaptability and resilience.

Eyes on the horizon

The shift towards real-time financial information and predictive intelligence is fundamentally changing the role of finance. As businesses gain access to more timely insights, finance professionals will increasingly be expected to anticipate challenges, inform strategic decisions and provide proactive advice throughout the year.

The AI reality

AI and automation are moving from experimentation into everyday business operations, creating opportunities to improve efficiency and reduce repetitive work. Their success will depend on how effectively organisations combine technology with human expertise, judgement and oversight, while developing the skills their people will need in the future.

Cybersecurity is a finance issue

Greater reliance on technology brings increased exposure to cyber threats, data protection risks and operational vulnerabilities. The report predicts that finance leaders will need to take greater ownership of these challenges, working across their organisations to strengthen governance, protect information and build resilience.

Beyond these five trends, the report examines how expectations of finance professionals and external advisers are changing. Businesses increasingly expect finance teams to move beyond traditional reporting and compliance, taking a more active role in shaping strategy, managing risk and identifying opportunities.

This shift is also influencing relationships with external advisers. Some 39% of respondents say they will seek more proactive, year-round advice rather than compliance-focused services, while 25% expect to consolidate more services with a single trusted partner.

Chris Horne added:

“The future of finance is about much more than new technology. It is about the people, skills and expertise needed to help businesses navigate change and make better decisions.”

“For Azets, these findings reinforce the importance of combining deep local knowledge with international expertise, progressive technology and proactive advice. Businesses need partners who understand their ambitions, can anticipate the challenges ahead and help them turn opportunities into results.”

The full report, The Future of Finance: Azets Predicts, is available at: https://www.azets.com/en-uk/resources/the-future-of-finance/future-of-finance-2027 

About the Future of Finance report

Future of Finance is an independent research study commissioned by Azets and conducted by Reputation Leaders. All data is based on a survey of 241 C-suite executives, senior leaders and finance decision-makers in the UK, Ireland, Denmark, Finland, Norway, and Sweden, conducted in September 2026.

Respondents represent organisations of significant scale: 82% employ more than 250 people, and 79% have annual turnover above €50 million.

For more information, visit https://www.azets.com/en-uk/resources/the-future-of-finance/future-of-finance-2027 

About Azets

Azets is an international business advisory group, with 9,000 local experts in 190 locations across eight countries, backed by progressive technology. We are united by one clear purpose: to improve the lives of our clients, colleagues and communities in a sustainable way.

100,000+ clients on unique journeys trust us to meet their immediate and evolving needs, remove barriers, and deliver sustained outcomes so they can move forward with confidence.

azets.com 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/european-business-leaders-back-growth-despite-economic-uncertainty-as-azets-launches-international-future-of-finance-report-302944176.html

Continue Reading

Trending